Addition of obinutuzumab (GA101) or rituximab to chlorambucil Improves ... EIN News (press release) The CLL11 trial conducted by the German CLL Study Group (GCLLSG) in collaboration with Hoffmann-La Roche for the first time compares directly the following treatments in elderly patients with comorbidities: GA101 plus chlorambucil, rituximab plus ... |
